COVID-19: Change in ISIPO services
Information for ISIPO customers and external partners.
Last updated: 13 May 2020
The reception at our office, Engjateigur 3 Reykjavík, will reopen Monday May 18th after temporary closure due to the COVID-19 outbreak. Customers are advised to familiarize themselves with the available means to complete the necessary tasks during this situation, including online services:
- Website: Customers can file applications, book services and receive answers for most IP inquiries on our website, www.isipo.is. Applications that can not be filed electronically can be sent via email: email@example.com.
- Email: Other inquiries can be sent via email: firstname.lastname@example.org.
- Telephone: The ISIPO's telephone center is is open all weekdays from 10-15. Telephone: 580 9400.
- Web Chat at www.hugverk.is (bottom right corner). Open from 10-15 every weekday.
- Mail: In case electronic services are not available, please send your inquiry via post to Hugverkastofan, Engjateigur 3, 105 Reykjavík.
Due to the COVID-19 epidemic and its possible effect on the operations of legal entities and individuals the ISIPO has decided to extend all deadlines until May 4 2020. This applies to all deadlines that are decided by the ISIPO, such as deadlines for submitting documents or written arguments. The extension does not, however, affect deadlines which are determined by law or regulations, such as those pertaining to priority, for submitting oppositions, to resuming case processing after the rejection of an application, to renewal and to the payment of fees.
If the COVID-19 epidemic causes a failure to meet a specific deadline, which is decided by law or regulation, it may be possible to request a re-establishment of the relevant application or the granted/registered right, subject to certain conditions as provided in the relevant act of law. A written request pertaining thereto should be sent to the ISIPO within the relevant time limit. In a request for such re-establishment, the COVID-19 situation should be mentioned.
COVID-19 news from other IPR authorities